Arius S.A.

Several Hybridon Presentations Highlight Early Cancer Platform.
BIOWORLD Today; 11/4/2009; 1424 words; ...second study, treatment with Hybridon's antisense compound targeted against Mdm2...decreased. In other news from the meeting: Arius Research Inc., of Toronto, reported preclinical...under way at medical centers in the U.S., based on the earlier results. To be...

Other News To Note.
BIOWORLD Today; 11/4/2009; 3276 words; ...added to the Standard & Poor's ASX 300 Index. o Allos Therapeutics...University of California at San Diego's translational medicine program...Jennings will lead the company's efforts to develop and commercialize...officer at Pain Therapeutics. o Arius Research Inc., of Toronto...

Arius Lines Up Functional' Antibodies Against Cancer.
BIOWORLD Today; 11/4/2009; 1187 words; ...president of Toronto-based Arius, about the company's treatment method. "The...profile of a given patient's disease. Arius has assembled more than...ones you want. That's where our technology comes in." Arius screens "directly for...

Appointments And Advancements.
BIOWORLD Today; 11/3/2009; 1145 words; ...sales and marketing of its CombiMatrix group's subsidiary, Combimatrix Molecular Diagnostics Inc. Arius Research Inc., of Toronto, appointed Joseph...appointed J. Michael French as president of its U.S. subsidiary, Rosetta Genomics Inc. SinoBiomed...

U.S. Patent Disclosures.
BIOWORLD Today; 11/3/2009; 978 words; Arius Research Inc., of Toronto, was granted U.S. Patent No. 7,189...company also received U.S. Patent No. 7,252...breast cancer. Separately, Arius was granted two additional...patents for antibodies: U.S. Patent No. 7,256...